Structure of the drug treatment adherence in elderly patients with mild cognitive impairment and psychopathological symptoms

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. The high prevalence of pre-dementia cognitive impairment in the elderly, their poor prognosis with a frequent transition to dementia, polymorbidity with somatic pathology determine the need for adequate correction of all somatic diseases. This increases the importance of treatment adherence.

Aim. To assess the structure of drug treatment adherence in elderly patients with mild cognitive impairment (MCI) and psychopathological symptoms.

Material and methods. An observational study of 264 patients diagnosed with mild cognitive impairment was conducted. The average age was 68.5±1.4 years. Of these, 17.6% were men, and 83.3% were women. The patients were divided into two groups: with psychopathological symptoms (main group, n=189) and without psychopathological symptoms (comparison group, n=75). Research methods used: clinical-psychopathological, psychometric, statistical by using Statistica 7 software for Windows OS. The Pearson's chi-squared test, the nonparametric Mann–Whitney U test, and the correlation analysis with calculation of Spearman’s rank correlation coefficient (r) were used.

Results. The adherence (compliance) of the study participants in relation to general therapeutic recommendations is represented by social, emotional and behavioural compliance. The total score of general compliance in the main study group was 45.42±29.7, in the comparison group — 51.09±32.3 points (p=0.031). In the main group, half of the participants (49.7%) had a low total score of general compliance, less than half of the participants had an average total score, only 4.8% of the participants showed high compliance with therapeutic recommendations. Increased depression correlates with low overall, social and emotional competence (r=0.512). Severe agitation and aggression correlate with low behavioural and emotional competence (r=0.589). Statistically significant correlations were found between psychotic symptoms and low behavioural compliance (r=0.151 and r=0.145).

Conclusion. The overall medication compliance rates are lower in patients with affective and psychotic symptoms; an increase in the number of affective, psychotic, behavioural disorders in patients with mild cognitive impairment correlates with low overall, social, emotional and behavioural compliance.

Full Text

Restricted Access

About the authors

Olga P Kovtun

Ural State Medical University

Email: kovtun@usma.ru
ORCID iD: 0000-0002-5250-7351

MD, Corresponding Member of the Russian Academy of Sciences, D.Sc. (Med.), Prof., Rector

Russian Federation, Yekaterinburg, Russia

Alena P Sidenkova

Ural State Medical University

Author for correspondence.
Email: sidenkovs@mail.ru
ORCID iD: 0000-0001-5142-3992

MD, D.Sc. (Med.), Prof., Head, Depart. of Psychiatry, Psychotherapy and Narcology

Russian Federation, Yekaterinburg, Russia

Nadezhda V Izmozherova

Ural State Medical University

Email: nadezhda_izm@mail.ru
ORCID iD: 0000-0001-7826-9657

MD, D.Sc. (Med.), Prof., Head, Depart. of Pharmacology and Clinical Pharmacology

Russian Federation, Yekaterinburg, Russia

Oleg V Serdyuk

Sverdlovsk Regional Clinical Psychiatric Hospital

Email: ovs1303@gmail.com
ORCID iD: 0000-0002-9536-0329

MD, psychiatrist

Russian Federation, Yekaterinburg, Russia

Anna A Vikhareva

Ural State Medical University

Email: anna1993vi@gmail.com
ORCID iD: 0000-0002-5951-2110

MD, Assistant, Depart. of Pharmacology and Clinical Pharmacology

Russian Federation, Yekaterinburg, Russia

Alena A Melnik

Ural State Medical University

Email: alena.melnik.94@inbox.ru
ORCID iD: 0000-0002-4218-6603

MD, Assistant, Depart. of Psychiatry, Psychotherapy and Narcology

Russian Federation, Yekaterinburg, Russia

Alexey V Rezaikin

Ural State Medical University

Email: alexrez@yandex.ru
ORCID iD: 0000-0002-8665-5299

MD, Assoc. Prof., Depart. of Medical Physics, Informatics and Mathematics

Russian Federation, Yekaterinburg, Russia

References

  1. Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, Epelbaum S, Frisoni GB, Gauthier S, Genthon R, Gouw AA, Habert MO, Holtzman DM, Kivipelto M, Lista S, Molinuevo JL, O'Bryant SE, Rabinovici GD, Rowe C, Salloway S, Schneider LS, Sperling R, Teichmann M, Carrillo MC, Cummings J, Jack CRJr; Procee­dings of the Meeting of the International Working Group (IWG) and the American Alzheimer's Association on “The Preclinical State of AD”; July 23, 2015; Washington DC, USA. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12(3):292–323. doi: 10.1016/j.jalz.2016.02.002.
  2. Myakotnykh VS, Ostapchuk ES, Meshchaninov VN, Sidenkova AP, Borovkova TA, Toggashov MN, Shcherbakov DL. Patologicheskoestarenie: osnovnye «misheni», vozrast-assotsiirovannyezabolevaniya, gendernyeosobennosti, geroprofilaktika. (Pathological ­aging: main “targets”, age-associated diseases, gender cha­racteristics, geroprophylaxis.) Moskva: Novyj format; 2021. 342 р. (In Russ.)
  3. Reinhardt MM, Cohen CI. Late-lifepsychosis: dia­gnosis and treatment. Curr Psychiatry Rep. 2015;17(2):1. doi: 10.1007/s11920-014-0542-0.
  4. Sidenkova AP. Dynamic analysis of psychosocial factors of compliance for a long therapy of dementia. Psikhiatriya. 2016;(1):27–33. (In Russ.)
  5. Kamaradova D, Latalova K, Prasko J, Kubinek R, Vrbo­va K, Mainerova B, Cinculova A, Ociskova M, Holu­bova M, Smoldasova J, Tichackova A. Connection between self-stigma, adherence to treatment, and discontinuation of medication. Patient Prefer Adherence. 2016;10:1289–1298. doi: 10.2147/PPA.S99136.
  6. Rosa MA, Marcolin MA, Elkis H. Evaluation of the factors interfering with drug treatment compliance among Brasilian patients with schizophrenia. Revista Brasileira de Prisqiuatria. 2005;27(3):178–184.doi: 10.1590/S1516-44462005000300005.
  7. Serdyuk OV, Sidenkova AP, Khiliuk DA. Clinical and Dynamic Features and Prognostic Value of Non-Cognitive Psychopathological Symptoms in Mild Cognitive Impairment (MCI). Psikhiatriya. 2021;19(2):17–29. (In Russ.) doi: 10.30629/2618-6667-2021-19-2-17-28.
  8. Lutova NB. Compliance and psychopathological symptoms. VM Bekhterev review of psychiarty and medical psychology. 2012;(3):59–65. (In Russ.)
  9. Ma F, Wu T, Miao R, Xiao YY, Zhang W, Huang G. Conversion of mild cognitive impairment to dementia among subjects with diabetes: a population-based study of incidence and risk factors with five years of follow-up. J Alzheimers Dis. 2015;43(4):1441–1449. doi: 10.3233/JAD-141566.
  10. Coca A, Monteagudo E, Doménech M, Camafort M, Sierra C. Can the treatment of hypertension in the middle-aged prevent dementia in the elderly? High Blood Press Cardiovasc Prev. 2016;23(2):97–104. doi: 10.1007/s40292-016-0144-5.
  11. GLOBAL STATUS REPORT on noncommunicable diseases 2014. WHO; 2014. 302 p.
  12. Wu L, Sun D. Adherence to Mediterranean diet and risk of developing cognitive disorders: an updated syste­matic review and meta-analysis of prospective cohort stu­dies. Sci Rep. 2017;7:41317. doi: 10.1038/srep41317.
  13. Avedisova AS. The problems of long-term therapy of chronic diseases: compliance — refusal of therapy — motivation for treatment . 2012;(48):64–70. (In Russ.)
  14. Nelson AM, Wood SD, Brown S. Alafuzoff I, Bigio EH. Improving patient satisfaction now: how to earn patient and payer loyalty. Gaithersburg, MD: Aspen Publishers Inc.; 1997. 342 p.
  15. Cerkoney KA, Hart LK. The relationship between the health belief model and compliance of persons with dia­betes mellitus. Diabetes Care. 1980;3(5):594–598. doi: 10.2337/diacare.3.5.594.
  16. Sidenkova AP, Izmozherova NV, Serdyuk OV, Kovrizhnykh IV, Saifullina AM, Garifullina ER. Theoretical aspects of the compliance problem.. Ural'skiy meditsinskiy zhurnal. 2019;(14):5–12. (In Russ.) doi: 10.25694/URMJ.2019.14.05.
  17. Anderson RM. Patient empowerment and the traditional medical model. Acase of irreconcilable differences? Diabetes Care. 1995;18(3):412–415. doi: 10.2337/diacare.18.3.412.
  18. Mendelevich VD. Klinicheskayai me­ditsinskaya psikhologiya. Prakticheskoe rukovodstvo. (Clinical and medical psychology. Practical guide.) Moscow: MEDpress; 1988. 592 р. (In Russ.)
  19. Kadyrov RV, Asriyan OB, Koval'chuk SA. Oprosnik “Uroven' komplaentnosti”. (Questionnaire “Compliance level”.) Vladivostok: Рor. gos. un-t; 2014. 74 р. (In Russ.)

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Рис. 1. Распределение участников основной группы по некогнитивным подгруппам

Download (10KB)
3. Рис. 2. Распределение участников исследования по уровню комплаентности

Download (25KB)
4. Рис. 3. Выраженность структурных компонентов комплаентности в группах исследования

Download (59KB)

© 2022 Eco-Vector





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies